Tuberculosis Diagnosis

NIAID supports the development of new and improved diagnostic tools for faster and more accurate diagnosis of early tuberculosis (TB) disease and Mycobacterium tuberculosis (Mtb) infection, to help optimize therapy by identifying drug-resistant strains, and to track the spread of TB in a community. The Institute also encourages researchers to develop tools and identify biomarkers that allow clinicians to rapidly assess how people respond to therapy and to assist in conducting drug and vaccine clinical trials.

Content last reviewed on October 27, 2016